Products
Investing
Resources
Credit Cards
Tools & Calculators
Support
Eris Lifesciences Limited (ERIS)
₹1,269.2
INR+1.15(+0.09%)
As of March 12, 2025 9:20:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹17287.20 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹20141.38 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
52.49
Forward P/E
Price to Earnings ratio based on forecasted earnings
30.45
PEG Ratio
Price/Earnings to Growth ratio
30.45
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
6.35
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
75.51%
Operating Margin
Operating income as a percentage of revenue
23.42%
Return on Equity
Net income as a percentage of shareholders' equity
12.17%
Revenue (TTM)
Total revenue over trailing 12 months
₹2723.92 Cr+49.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹938.80 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹24.16-18.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹242.55 Cr
Total Debt
Total short-term and long-term debt
₹2734.83 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
86.08%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹809.15 - ₹1593.9
Beta
Measure of stock's volatility compared to the market
0.28
Shares Outstanding
Total number of shares issued by the company
₹13.60 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.16%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
NA